NasdaqGS - Delayed Quote USD
Gossamer Bio, Inc. (GOSS)
1.2500
+0.0700
+(5.93%)
At close: May 5 at 4:00:00 PM EDT
1.2600
+0.01
+(0.80%)
After hours: May 5 at 7:59:16 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,468
-3,468
-159,158
-187,032
-188,890
Investing Cash Flow
29,023
29,023
-110,970
-1,035
-117,427
Financing Cash Flow
-11,488
-11,488
190,154
117,090
3,329
End Cash Position
46,074
46,074
32,109
111,973
183,467
Interest Paid Supplemental Data
10,561
10,561
12,288
12,712
12,738
Capital Expenditure
--
--
--
-475
-1,621
Issuance of Capital Stock
--
--
201,323
119,946
--
Repayment of Debt
-12,581
-12,581
-11,613
-5,806
--
Free Cash Flow
-3,468
-3,468
-159,158
-187,507
-190,511
12/31/2021 - 2/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALEC Alector, Inc.
1.1600
-10.77%
HOOK HOOKIPA Pharma Inc.
1.2800
-4.48%
STOK Stoke Therapeutics, Inc.
9.70
+0.73%
SPRB Spruce Biosciences, Inc.
0.0739
+7.88%
NUVB Nuvation Bio Inc.
2.3800
-3.25%
MRSN Mersana Therapeutics, Inc.
0.3650
-8.22%
BDTX Black Diamond Therapeutics, Inc.
1.6700
-6.18%
STRO Sutro Biopharma, Inc.
1.0500
-4.55%
ETNB 89bio, Inc.
8.61
-1.37%
INZY Inozyme Pharma, Inc.
1.4900
-8.02%